1. Academic Validation
  2. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level

C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level

  • Immunobiology. 2004;209(1-2):141-54. doi: 10.1016/j.imbio.2004.02.006.
Marion Jurk 1 Bettina Schulte Andrea Kritzler Bernhard Noll Eugen Uhlmann Tanja Wader Christian Schetter Arthur M Krieg Jörg Vollmer
Affiliations

Affiliation

  • 1 Coley Pharmaceutical GmbH, Elisabeth-Selbert-Str. 9, D-40764 Langenfeld, Germany. [email protected]
Abstract

Synthetic oligodeoxynucleotides (ODN) containing unmethylated deoxycytosine-deoxyguanosine (CpG) motifs are very potent inducers of the innate immune system, mimicking the effects of Bacterial DNA. CpG ODN are recognized by Toll-like Receptor 9 (TLR9). Three classes of TLR9 agonists have been described: B-Class CpG ODN that induce strong B- and NK-cell activation and A-Class ODN that induce very high levels of IFN-alpha by plasmacytoid dendritic cells. The recently described C-Class ODN combine most efficiently properties of A- and B-Class ODN in that they induce strong B-cell activation comparable to B-Class ODN together with IFN-alpha secretion comparable to A-Class ODN. Here, we investigate sequence requirements of C-Class ODN regarding optimal IFN-alpha secretion. Sequence as well as backbone modifications like 2'-O-methyl modifications especially in the 5' part of the ODN influence IFN-alpha-producing capacity. Kinetic studies on mRNA level for CD69, IFN-gamma, IP-10 and IL-18 by semi-quantitative PCR demonstrated differences in mRNA transcription for some cytokines suggesting different regulatory mechanisms for different ODN classes. High amounts of IP-10 mRNA and protein as well as up-regulation of IL-18 mRNA were observed especially for the A- and C-Classes. According to these data, C-Class ODN can be described as strong Th1 inducers with the stimulation of type I and II interferon as well as IP-10 production and strong NK activation. These characteristics can be availed to induce potent anti-tumor or anti-viral effects. Consequently, C-Class CpG ODN represent ideal drug candidates for anti-viral and/or anti-tumor therapy.

Figures
Products